---
$id: https://graph.org.ai/products/commodity/51131706
$type: Product
source: UNSPSC
code: "51131706"
title: "Argatroban"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Argatroban

**UNSPSC Code**: 51131706
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IY90U61Z3S. European Medicines Agency schedules Argatroban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05559MIG. Argatroban generally arises in the molecular formula C23H36N6O5S. The term ARGATROBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 1 1998, list 39.) ARGATROBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule argatroban under HS 29350090 and SITC 51580. As of Q4 2014, ARGATROBAN remains the US FDA Preferred Term for this commodity. Argatroban bears US NLM identifiers UMLS ID C0048470 and NCI Concept Code C28833. SMILES: CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C.O.

